Dataset: Expression data of HUVEC cells after PPARβ/δ agonist and/or hypoxia treatment
Recently the role of PPARβ/δ in angiogenesis has been revealed, and we hypothesized that the crosstalk between hypoxia and PPARβ/δ on...
Recently the role of PPARβ/δ in angiogenesis has been revealed, and we hypothesized that the crosstalk between hypoxia and PPARβ/δ on endothelial cells may exsist. To elucidate the interaction between two signalings, we report the comprehensive change of transcripts induced by PPARβ/δ agonist (GW501516) and/or hypoxia. We used microarray analysis of HUVECs treated with PPARβ/δ agonist (GW501516) and/or hypoxia (1% O2) for 24-hours, and we identified a group of consistently up- or down-regulated genes. HUVECs were used within the first 6 passages. HUVECs were treated with PPARβ/δ agonist (GW501516) at a concentration of 100 nM and/or hypoxia (1% O2) for 24-hours. Same concentration of DMSO was used as a control sample, and as to the oxgen, normoxia was used as a control condition.
- Species:
- human
- Samples:
- 4
- Source:
- E-GEOD-50378
- Updated:
- Dec.12, 2014
- Registered:
- Jul.11, 2014
Sample | PPARD TREATMENT | OXYGEN CONDITION |
---|---|---|
GSM1217734 | PPARβ/δ agonist | normoxia |
GSM1217733 | PPARβ/δ agonist | hypoxia |
GSM1217732 | DMSO | normoxia |
GSM121773 | DMSO | hypoxia |